Johnson & Johnson COVID-19 Vaccinations Resume: Understanding Risks and Benefits
The Centers for Disease Control and Prevention and the Food and Drug Administration lifted the pause on the Johnson & ...
Tag: Editor Pick
UC Davis and SpectraPass Partner on Rapid Mass Spec COVID-19 Test
The novel COVID-19 test uses a mass spectrometer paired with a powerful machine-learning platform to detect SARS-CoV-2 in nasal swabs. ...
University of Bristol Scientists Form Halo Therapeutics to Develop ‘Pan-Corona’ Antivirals
A team of top scientists from the University of Bristol have announced the formation of a new biotech company that ...
New Initiative to Support Studies of the Bat Immune System
Understanding the mechanisms of how bats regulate immune responses to clear infections and prevent excessive inflammation may lead to a ...
National Vaccine Trial Will Focus on Those with History of Severe Allergies or Mast Cell Disorder
In a carefully controlled clinical trial, Michigan Medicine researchers will examine whether participants who are highly allergic or have a ...
Duke University Develops Portable Diagnostic to Detect Early Biomarkers of Ebola Virus
An interdisciplinary team of scientists at Duke University has developed a highly sensitive and rapid diagnostic test for Ebola virus ...
CDC Awards $3 Billion in Wide-Reaching Campaign to Boost Vaccination Uptake
The U.S. Centers for Disease Control and Prevention (CDC) has awarded funding to support local efforts to increase vaccine uptake ...
Bacteria ‘Shuffle’ Their Genetics Around to Develop Antibiotic Resistance on Demand
Antibiotic resistance – the ability of harmful bacteria to survive treatment by antibiotics – is a growing threat. It is ...
Increased Transmissibility of SARS-CoV-2 Variants of Concern Not Likely Due to Increased Environmental Survivability
The deactivating effects of heat and sunlight on SARS-CoV-2, the virus that causes COVID-19, are consistent across different variants of ...
New Insights on Cause of Rare Anaphylaxis Following COVID-19 Vaccination
On the first day of the UK campaign for COVID-19 vaccination, there were reports of two cases of anaphylaxis--a severe, ...
COVID-19: Men Create More Antibodies After Asymptomatic Infection, and Keep Them Longer
As COVID-19 has swept across the globe, it seems that high transmission rates have partly been driven by a large ...
Pattern of Dominance: B.1.1.7 Variant 40-50 Percent More Transmissible, Spreading Rapidly in U.S.
The faster-spreading B.1.1.7 variant of SARS-CoV-2 first detected in the United Kingdom is quickly on its way to becoming the ...
Genomic Surveillance: Why We Need to Ramp Up Sequencing to End the Pandemic
“You can’t fix what you don’t measure” is a maxim in the business world. And it holds true in the ...
Ebola Might Be a Chronic Infection – But Here’s Why We Shouldn’t Panic
Ebola is back in Guinea in West Africa, five years after the largest Ebola epidemic ever known ended – but ...
How to Reduce PPE Facial Pressure Injuries in Frontline Health Care Workers
A new study has found that arming frontline workers with a 'care bundle' of baby wipes, Aquaphor and silicone tape ...
Technique for Testing Biosensor Materials Could Aid Noninvasive Diagnostic Development
The efficacy of biosensors used in clinical tests depends critically on the surface of the device on which the biorecognition ...
New Study Confirms Covid-19 Link to Hearing Loss, Tinnitus and Vertigo
Some viruses, such as measles, mumps and meningitis, can cause hearing difficulties, but what about SARS-CoV-2, the virus that causes ...
How Good Is the AstraZeneca Vaccine – And Is It Really Safe?
Over the past few months, there have been concerns over how effective and how safe the AstraZeneca COVID-19 vaccine really ...
People Gave Up on Flu Pandemic Measures a Century Ago When They Tired of Them – and Paid a Price
Picture the United States struggling to deal with a deadly pandemic. State and local officials enact a slate of social-distancing ...
How Effective is the First Shot of the Pfizer or Moderna Vaccine?
As the COVID-19 vaccines reach more people across the country, some people have asked: Could we delay the second dose ...
